Description of the medicine: Oxyferriscorbone sodium (Oxyferriscorbone natrium)
SODIUM OXIFERRISCORBON (Oxyferriscorbone natrium) *.
Synonym: Oxyferriscorbone sodique.
A preparation containing dibasic and tribasic iron in combination with the sodium salts of 2, 3-dioxo-1-gulonic and alloxonic acids.
Unlike other iron-containing drugs, sodium oxyferriscorbone is not used for iron deficiency anemia, but as a treatment for peptic ulcer of the stomach and duodenum. The drug has some anti-inflammatory and analgesic effects and contributes to the scarring process.
In connection with the emergence of new modern anti-ulcer drugs (see Cimetidine, Ranitidine and other blockers of H 2 receptors, Pirenzepine, Sucralfate, etc.), the use of sodium oxyferrisorbine has become limited.
The drug is administered intramuscularly. In case of gastric ulcer, 30-60 mg are administered daily (contents of 1 to 2 vials) for 10 to 20 days. After a 20-day break, the course of treatment is repeated. Repeated courses are carried out intermittently, depending on the effect obtained. For intestinal ulcers, 15-30 mg is administered daily for 6-8 weeks.
The drug is diluted before use in an isotonic sodium chloride solution (2 ml of solvent per 15 mg of the drug; 3 ml per 30 mg). You can enter the drug intramuscularly in a mixture with the blood of a patient taken from a vein (2-3 ml). In this case, take half the dose of the drug.
Oxyferriscorbone sodium can be administered in the same syringe with novocaine, atropine sulfate, but not with other drugs.
Release form: 30 mg lyophilized powder in vials with the application of an ampoule with a solvent (5 ml of isotonic sodium chloride solution).